Janssen J&J
Owners
Janssen is a pharmaceutical division of an international corporation Johnson & Johnson. Today, Janssen, one of the leaders in the pharmaceutical sector in Russia, makes a significant contribution to the development of the healthcare system. Janssen seeks solutions to serious medical problems such as oncology (multiple myeloma and prostate cancer), immunology (psoriasis), psychiatry (schizophrenia, Alzheimer's disease), infectious diseases (HIV/AIDS, Hepatitis C and tuberculosis), as well as cardiovascular diseases and metabolic disorders (diabetes).
The pharmaceutical division of Johnson & Johnson International Corporation carries out commercial activities in the Russian Federation through Johnson & Johnson LLC.
History
2020: Launch of COVID-19 vaccine development
Main article: Johnson & Johnson vaccine from COVID-19
Vaccine JNJ-78436735 is being developed by Janssen, a pharmaceutical company of Johnson & Johnson.
| The site content is translated by machine translation software powered by PROMT. The machine-translated articles are not always perfect and may contain errors in vocabulary, syntax or grammar. Read original article If you find inaccuracies or errors in the results of machine translation, please write to editor@tadviser.ru. We will make every effort to correct them as soon as possible. |